Effects of TENS and Mindfulness Meditation in Persons With HIV-related Neuropathy

  • End date
    May 30, 2023
  • participants needed
  • sponsor
    Rutgers University
Updated on 4 October 2022
antiretroviral therapy


This study is to explore the effects of transcutaneous nerve stimulation (TENS) and mindfulness meditation in persons living with HIV (PLHIV) and painful neuropathy in the feet.


The overall goal of this study is to conduct an interventional pilot trial of mindfulness meditation and transcutaneous nerve stimulation (TENS) to mitigate the symptoms and improved function in persons living with HIV (PLHIV) and painful neuropathy in the feet. .

The investigators aim to determine the feasibility and effects of (1) mindfulness meditation or (2) transcutaneous nerve stimulation (TENS) on clinical and functional outcomes in participants with HIV-associated painful distal sensory polyneuropathy in the feet. This aim will be achieved with a randomized control pilot trial with 3 groups: TENS group, Mindfulness Mediation Group, and Usual Treatment (Control) group. The interventions will be performed at home over a period of 6 weeks.

Condition HIV Infections
Treatment Mindfulness Meditation, Transcutaneous Nerve Stimulation (TENS)
Clinical Study IdentifierNCT04868123
SponsorRutgers University
Last Modified on4 October 2022


Yes No Not Sure

Inclusion Criteria

diagnosis of HIV infection currently treated with antiretroviral therapy (ART)
cluster of differentiation 4 cell (CD4 cell) count of at least 200 cells/mm3
-64 years of age
able to read and write in English
means to travel to a study site
presence of peripheral neuropathy symptoms in feet
average daily self-reported pain in the feet of at least 3/10 on a 0-10 numerical pain scale
pain in the feet present for at least the past 3 months
no changes in medications used to manage pain in the past 4 weeks
no use of TENS or mindfulness meditation in the prior 6 months
availability of a mobile phone to receive text messages over the course of the intervention period

Exclusion Criteria

current opportunistic infection(s)
cluster of differentiation 4 cell (CD4 cell) count <200 cells/mm3
uncontrolled psychiatric disorder
wounds or sores on the feet
musculoskeletal or neurological conditions (other than distal sensory neuropathy) that may affect gait
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note